The study found that the use of the company’s computer-assisted vacuum thrombectomy (CAVT) system, a form of mechanical ...

Penumbra, Inc. announced the results of the landmark STORM-PE randomized controlled trial (RCT), which found that the use of mechanical thrombectomy, specifically computer assisted vacuum thrombectomy ...

Shortness of breath when walking short distances can occur suddenly or be a chronic condition. It should be evaluated, as it ...

Pulmonary embolism (PE), a type of blood clot in the lungs, sends more than half a million people to U.S. hospitals each year ...

Jupiter Endovascular today announced positive results from the first-in-human study of its Vertex pulmonary embolectomy ...

The first of its kind RCT in acute intermediate-high-risk PE used a surrogate endpoint, but more data are on the horizon.

Jupiter Endovascular, Inc., a medical technology company developing a new class of endovascular interventions using its proprietary Transforming Fixation (TFX) technology, today announced positive ...

Angiodynamics, Inc. (($ANGO)) announced an update on their ongoing clinical study. Study Overview: AngioDynamics, Inc. is conducting a ...

Thrombolex, Inc. announced findings from a prespecified interim analysis from the first 50 patients in the postmarket RAPID-PE ...

The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the company a successor to its blockbuster therapy Ofev. Phosphodiesterase (PDE ...